PPT-The Diabetic Retinopathy Clinical Research Network

Prompt PRP vs Ranibizumab Deferred PRP for PDR Study Supported through a cooperative agreement from the National Eye Institute and the National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Department of Health and Human Services EY14231 EY14229 EY018817 . Jean Escalante. Kristin . Filkins. Erika Garcia.  . SPE-516 Structure . and Function of the Visual System. What is Retinopathy of Prematurity?. When an infant is born early or not completely developed their eyes may be lacking in development as well. . Carmen . Leyva. . Vicki Herrin . Hampton Huddleston. Stephen F. Austin State University. What is Macular Degeneration?. Macular Degeneration is the progressive deterioration of the macula, the light-sensitive cells of the central retina, at the back of the eye. As the macular cells malfunction and die, central vision becomes gray, distorted and is eventually lost. Peripheral vision does not become affected. . Faculty of medicine. Ophthalmology department. Diabetic Retinopathy. Supervisor Dr.Mohammed Ramadan. Done by:. Alaa' Mohammed al.Gharib…..1102. Amany Zohair Tabash………...1103. Abbas Waleed Iter…..............…1104. Nissen. , . Cydney. Williams. Diabetic Retinopathy. What is diabetic retinopathy?. Diabetic retinopathy is a complication of diabetes that occurs when the disease damages tiny blood vessels inside the retina. Elevated levels of blood glucose harm these blood vessels, usually causing blindness in both eyes.. Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. Eye Screening Service. Stephanie Holland, Service Manager and Dr Philip Haynes, GP Brookside Practice. Aims:. To reduce the risk of sight loss amongst people with diabetes by a systematic screening programme for diabetic retinopathy that fully complies with the national standards set by the NHS Diabetic Eye Screening Programme (NHS DESP).. (DR) . Ayesha S Abdullah. 03.01.2014. Learning outcomes. By . the end of the lecture the students would be able . to;. Describe the epidemiology of DR. Correlate the pathogenesis of DR with the clinical . Torres Strait Islander people. Key facts. Information to assist health care providers in their everyday practice. These key facts have been developed by . the . Australian . Indigenous . Heath. InfoNet. Dr. Faryal Baddia. Objectives. General. Specific. Type of study design. Data collection method. “. Guidelines for developing DR Program in India. . By . Arvind. Eye Care System.”. Materials & Methods. MD. Shahid. . Beheshti. University Of Medical Science. PREVALENCE OF DIABETIC RETINOPATHY. In 1980–82, the WESDR showed that 71%, 23%, and 11% . of those . with type 1 diabetes (insulin-dependent diabetes . .. Ramesh. S Ve . 1. *. , Singh Megha . 2. , Lakshmikantha Nandini . 3. , . Mayya. S. . Shreemathi. . 4. , Andrews Teddy . 2. . Affiliation (s). 1. Department Of Optometry, School of Allied Health Sciences, Manipal University, Manipal . Navjot Bilkhu, A.D. Wright, A. Farnsworth, S. Osei - Amoako, P.M. Dodson. Diabetic Retinopathy Screening Programme Birmingham, Black Country and Solihull (UK) Methods 68,637 patients were screened in INTNL. J. DIAB. DEV. COUNTRIES (1991), VOL. 11 The visually impaired diabetic patient faces problems in rnonitoring glucose levels, identifying the type of insulins, determining the amount of insulin Differentialdiagnosesincludeconditionssuchhypertensiveretinopathy,retinalarterialmacroaneuysmCoatsdiseaseandchoroidalneovascularisation CWS Fluid in ONL HEx Blot haemorrhage Diabeticretinopathy(DR)ret